Drug
ZL 3101
ZL 3101: highest development phase Phase 2, developed by Zai Lab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZL-3101 NCT03134352 | Phase 2 | Eczema |
Latest
No recent events.
Follow ZL 3101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.